Stroke, Vol 23, 641-645, Copyright © 1992 by American Heart Association
EC Haley Jr, DE Levy, TG Brott, GL Sheppard, MC Wong, GL Kongable, JC Torner and JR Marler
BACKGROUND AND PURPOSE: Renewed interest in thrombolytic therapy as
potential treatment for patients with acute ischemic stroke prompted a
dose-escalation safety study of tissue plasminogen activator in patients
with very early (less than or equal to 90 minutes; see Part I) neurological
symptoms. To test whether this stringent entry window might be safely
lengthened, a second study was organized to test tissue plasminogen
activator in patients with symptoms of 91-180 minutes' duration before
treatment. METHODS: An open-label, dose-escalation design was chosen.
Eligible patients had pretreatment head computerized tomographic scanning
and treatment begun 91-180 minutes from stroke onset. End points examined
included the incidence of symptomatic and asymptomatic intracranial
hemorrhage, other bleeding, and clinical outcome at 2 hours, 24 hours, and
3 months after treatment. RESULTS: Twenty patients were treated at three
hospitals in 13 months. Three doses were tested: 0.6 mg/kg (n = 8), 0.85
mg/kg (n = 6), and 0.95 mg/kg (n = 6). Two patients, one each at the two
highest doses, sustained fatal intracerebral hemorrhages. Three patients
(15%) improved by greater than or equal to 4 points on the National
Institutes of Health Stroke Scale by 24 hours. CONCLUSIONS: These
observations suggest that tissue plasminogen activator treatment of acute
ischemic stroke 91-180 minutes from onset in doses of greater than or equal
to 0.85 mg/kg is attended by a risk of intracerebral hemorrhage
approximating 17% (range 3-44%, 95% confidence interval). The rate of early
neurological improvement observed in this study was small but does not
exclude an improvement over the natural history. Future study with placebo
control subjects and stratification by time to treatment is indicated.
ARTICLES
Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset
Department of Neurology, University of Virginia School of Medicine, Charlottesville 22908.
This article has been cited by other articles:
 |
|
 |
|
  C.J. Dickinson Intracerebral haemorrhage revisited QJM, November 1, 2007; 100(11): 715 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.W. Kerber, I. Wanke, J. Bernard Jr., H.H. Woo, M.W. Liu, and P.K. Nelson Rapid Intracranial Clot Removal with a New Device: The Alligator Retriever AJNR Am. J. Neuroradiol., May 1, 2007; 28(5): 860 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Sattin, S. E. Olson, L. Liu, R. Raman, and P. D. Lyden An Expedited Code Stroke Protocol Is Feasible and Safe Stroke, December 1, 2006; 37(12): 2935 - 2939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. A. Tomsick 2006: A Stroke Odyssey AJNR Am. J. Neuroradiol., November 1, 2006; 27(10): 2019 - 2021. [Full Text] [PDF]
|
|
|
|
|
|
T. Yamaguchi, E. Mori, K. Minematsu, J. Nakagawara, K. Hashi, I. Saito, Y. Shinohara, and for the Japan Alteplase Clinical Trial (J-ACT) Gro Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset: Japan Alteplase Clinical Trial (J-ACT) * Supplemental Appendix 2 Stroke, July 1, 2006; 37(7): 1810 - 1815. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yong, H.-C. Diener, M. Kaste, and J. Mau Characteristics of Blood Pressure Profiles as Predictors of Long-Term Outcome After Acute Ischemic Stroke Stroke, December 1, 2005; 36(12): 2619 - 2625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Khatri, J. P. Broderick, A. M. Pancioli, E. C. Haley Jr, K. C. Johnston, P. D. Lyden, T. M. Hemmen, and For the TNK in Stroke Investigators Risk of Thrombolysis-Associated Intracerebral Hemorrhage: The Need to Compare Apples With Apples * Response: Stroke, June 1, 2005; 36(6): 1109 - 1110. [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Hill, A. M. Buchan, and for The Canadian Alteplase for Stroke Effectivenes Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study Can. Med. Assoc. J., May 10, 2005; 172(10): 1307 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Ingall, W. M. O'Fallon, K. Asplund, L. R. Goldfrank, V. S. Hertzberg, T. A. Louis, and T. J. H. Christianson Findings From the Reanalysis of the NINDS Tissue Plasminogen Activator for Acute Ischemic Stroke Treatment Trial Stroke, October 1, 2004; 35(10): 2418 - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Seitz, M. Hamzavi, U. Junghans, P. A. Ringleb, C. Schranz, and M. Siebler Thrombolysis With Recombinant Tissue Plasminogen Activator and Tirofiban in Stroke: Preliminary Observations Stroke, August 1, 2003; 34(8): 1932 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Castellanos, R. Leira, J. Serena, J. M. Pumar, I. Lizasoain, J. Castillo, A. Davalos, and G. F. Hamann Plasma Metalloproteinase-9 Concentration Predicts Hemorrhagic Transformation in Acute Ischemic Stroke * Editorial Comment Stroke, January 1, 2003; 34(1): 40 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.K. Gilligan, R. Markus, S. Read, V. Srikanth, T. Hirano, G. Fitt, M. Arends, B.R. Chambers, S.M. Davis, and G.A. Donnan Baseline Blood Pressure but Not Early Computed Tomography Changes Predicts Major Hemorrhage After Streptokinase in Acute Ischemic Stroke Stroke, September 1, 2002; 33(9): 2236 - 2242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Montaner, J. Alvarez-Sabin, C. Molina, A. Angles, S. Abilleira, J. Arenillas, M. A. Gonzalez, and J. Monasterio Matrix Metalloproteinase Expression After Human Cardioembolic Stroke: Temporal Profile and Relation to Neurological Impairment Stroke, August 1, 2001; 32(8): 1759 - 1766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tejima, Y. Katayama, Y. Suzuki, T. Kano, and E. H. Lo Hemorrhagic Transformation After Fibrinolysis With Tissue Plasminogen Activator : Evaluation of Role of Hypertension With Rat Thromboembolic Stroke Model Stroke, June 1, 2001; 32(6): 1336 - 1340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Grotta, K. M. A. Welch, S. C. Fagan, M. Lu, M. R. Frankel, T. Brott, S. R. Levine, P. D. Lyden, and P. D. Lyden Clinical Deterioration Following Improvement in the NINDS rt-PA Stroke Trial Stroke, March 1, 2001; 32(3): 661 - 668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A C Pereira, P J Martin, and E A Warburton Thrombolysis in acute ischaemic stroke Postgrad. Med. J., March 1, 2001; 77(905): 166 - 171. [Full Text]
|
|
|
|
 |
|
 G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Chest, January 1, 2001; 119(1_suppl): 300S - 320S. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Marler, B. C. Tilley, M. Lu, T. G. Brott, P. C. Lyden, J. C. Grotta, J. P. Broderick, S. R. Levine, M. P. Frankel, S. H. Horowitz, et al. Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study Neurology, December 12, 2000; 55(11): 1649 - 1655. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Hinchey and C. Benesch Thrombolytic Therapy in Patients With Acute Ischemic Stroke Arch Neurol, October 1, 2000; 57(10): 1430 - 1436. [Full Text] [PDF]
|
|
|
|
|
|
P. Trouillas, L. Derex, N. Nighoghossian, J. Honnorat, W. Li, P. Neuschwander, G. Riche, J. C. Getenet, Y. Berthezene, F. Turjman, et al. rtPA intravenous thrombolysis in anterior choroidal artery territory stroke Neurology, February 8, 2000; 54(3): 666 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yanamoto, I. Nagata, I. Nakahara, N. Tohnai, Z. Zhang, H. Kikuchi, and C. Iadecola Combination of Intraischemic and Postischemic Hypothermia Provides Potent and Persistent Neuroprotection Against Temporary Focal Ischemia in Rats • Editorial Comment Stroke, December 1, 1999; 30(12): 2720 - 2726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. I. Suarez, J. L. Sunshine, R. Tarr, O. Zaidat, W. R. Selman, C. Kernich, and D. M. D. Landis Predictors of Clinical Improvement, Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke Stroke, October 1, 1999; 30(10): 2094 - 2100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Lai, P. W. Duncan, and J. Keighley Prediction of Functional Outcome After Stroke : Comparison of the Orpington Prognostic Scale and the NIH Stroke Scale Stroke, September 1, 1998; 29(9): 1838 - 1842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Brott, M. Lu, R. Kothari, S. C. Fagan, M. Frankel, J. C. Grotta, J. Broderick, T. Kwiatkowski, C. Lewandowski, E. C. Haley Jr, et al. Hypertension and Its Treatment in the NINDS rt-PA Stroke Trial Stroke, August 1, 1998; 29(8): 1504 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Grond, C. Stenzel, S. Schmulling, J. Rudolf, M. Neveling, A. Lechleuthner, S. Schneweis, and W.-D. Heiss Early Intravenous Thrombolysis for Acute Ischemic Stroke in a Community-Based Approach Stroke, August 1, 1998; 29(8): 1544 - 1549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Pancioli, J. Broderick, R. Kothari, T. Brott, A. Tuchfarber, R. Miller, J. Khoury, and E. Jauch Public Perception of Stroke Warning Signs and Knowledge of Potential Risk Factors JAMA, April 22, 1998; 279(16): 1288 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Firlik, A. M. Kaufmann, L. R. Wechsler, K. S. Firlik, M. B. Fukui, and H. Yonas Quantitative Cerebral Blood Flow Determinations in Acute Ischemic Stroke : Relationship to Computed Tomography and Angiography Stroke, November 1, 1997; 28(11): 2208 - 2213. [Abstract] [Full Text]
|
|
|
|
|
|
T. F. Choudhri, B. L. Hoh, R. A. Solomon, E. S. Connolly Jr, and D. J. Pinsky Use of a Spectrophotometric Hemoglobin Assay to Objectively Quantify Intracerebral Hemorrhage in Mice Stroke, November 1, 1997; 28(11): 2296 - 2302. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. R. Caplan, J. P. Mohr, J. P. Kistler, W. Koroshetz, J. Grotta, L. R. Caplan, J. P. Mohr, J. P. Kistler, W. Koroshetz, and J. Grotta Should Thrombolytic Therapy Be the First-Line Treatment for Acute Ischemic Stroke? N. Engl. J. Med., October 30, 1997; 337(18): 1309 - 1313. [Full Text]
|
|
|
|
|
|
A Systems Approach to Immediate Evaluation and Management of Hyperacute Stroke : Experience at Eight Centers and Implications for Community Practice and Patient Care Stroke, August 1, 1997; 28(8): 1530 - 1540. [Abstract] [Full Text]
|
|
|
|
|
|
B. C. Tilley, J. Marler, N. L. Geller, M. Lu, J. Legler, T. Brott, P. Lyden, and J. Grotta Use of a Global Test for Multiple Outcomes in Stroke Trials With Application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial Stroke, November 1, 1996; 27(11): 2136 - 2142. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. P. Adams, T. G. Brott, A. J. Furlan, C. R. Gomez, J. Grotta, C. M. Helgason, T. Kwiatkowski, P. D. Lyden, J. R. Marler, J. Torner, et al. Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association Circulation, September 1, 1996; 94(5): 1167 - 1174. [Full Text]
|
|
|
|
|
|
P. Trouillas, N. Nighoghossian, J.-C. Getenet, G. Riche, P. Neuschwander, J.-C. Froment, F. Turjman, J.-X. Jin, D. Malicier, G. Fournier, et al. Open Trial of Intravenous Tissue Plasminogen Activator in Acute Carotid Territory Stroke : Correlations of Outcome With Clinical and Radiological Data Stroke, May 1, 1996; 27(5): 882 - 890. [Abstract] [Full Text]
|
|
|
|
|
|
The National Institute of Neurological Disorders a Tissue Plasminogen Activator for Acute Ischemic Stroke N. Engl. J. Med., December 14, 1995; 333(24): 1581 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Frey, K. A. Greene, M. H. Khayata, B. L. Dean, J. A. Hodak, and R. F. Spetzler Intrathrombus Administration of Tissue Plasminogen Activator in Acute Cerebrovascular Occlusion Angiology, August 1, 1995; 46(8): 649 - 656. [Abstract] [PDF]
|
|
|
|
 |
|
 A Working Group on Emergency Brain Resuscitation. Emergency Brain Resuscitation Ann Intern Med, April 15, 1995; 122(8): 622 - 627. [Abstract] [Full Text]
|
|
|
|
|
|
A. D. Perez-Trepichio, M. Xue, T. C. Ng, A. W. Majors, A. J. Furlan, I. A. Awad, and S. C. Jones Sensitivity of Magnetic Resonance Diffusion-Weighted Imaging and Regional Relationship Between the Apparent Diffusion Coefficient and Cerebral Blood Flow in Rat Focal Cerebral Ischemia Stroke, April 1, 1995; 26(4): 667 - 675. [Abstract] [Full Text]
|
|